Literature DB >> 30042985

Chronic rhinosinusitis exacerbations are differentially associated with lost productivity based on asthma status.

K M Phillips1, R W Bergmark1, L P Hoehle1, D S Caradonna2, S T Gray1, A R Sedaghat1.   

Abstract

BACKGROUND: The frequency of chronic rhinosinusitis (CRS) exacerbations is an independent predictor of quality of life. The objective of this study was to evaluate if increased CRS exacerbations predict decreased productivity.
METHODS: Cross-sectional study of adult CRS patients. Number of patient-reported CRS-related antibiotic and oral corticosteroids courses and sinus infections in the past three months were used as metrics for acute exacerbations of CRS (AECRS). Productivity loss was measured by asking participants the number of lost days of work or school due to CRS in the past three months. Associations were sought between lost productivity and AECRS, controlling for clinical and demographic characteristics.
RESULTS: 371 participants were recruited. 28.8% of study participants had comorbid asthma. The mean number of lost days of productivity due to CRS in the last three months was 1.5 for asthmatic participants and 2.4 for non-asthmatic participants. In asthmatics, CRS-related lost productivity was significantly associated with number of CRS-related antibiotics used (and oral corticosteroids used, with a trend for sinus infections. No AECRS metric was significantly associated with lost productivity in non-asthmatics. However, when focusing on non-asthmatics reporting missed days of work or school due to CRS, we found statistically significant associations between AECRS metrics and lost productivity.
CONCLUSIONS: The frequency of AECRS is associated with CRS-related lost productivity in asthmatics and in the subset of non-asthmatics with moderate CRS-related productivity losses.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30042985     DOI: 10.4193/Rhin18.033

Source DB:  PubMed          Journal:  Rhinology        ISSN: 0300-0729            Impact factor:   3.681


  5 in total

1.  Seasonal variations in chronic rhinosinusitis symptom burden may be explained by changes in mood.

Authors:  Rehab Talat; Katie M Phillips; David S Caradonna; Stacey T Gray; Ahmad R Sedaghat
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-07-15       Impact factor: 2.503

2.  Chronic rhinosinusitis disease burden is associated with asthma-related emergency department usage.

Authors:  Claire Gleadhill; Marlene M Speth; Isabelle Gengler; Katie M Phillips; Lloyd P Hoehle; David S Caradonna; Stacey T Gray; Ahmad R Sedaghat
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-08-04       Impact factor: 2.503

Review 3.  Immunostimulants in respiratory diseases: focus on Pidotimod.

Authors:  Francesca Puggioni; Magna Alves-Correia; Manar-Farouk Mohamed; Niccolò Stomeo; Riccardo Mager; Massimiliano Marinoni; Francesca Racca; Giovanni Paoletti; Gilda Varricchi; Veronica Giorgis; Giovanni Melioli; Giorgio Walter Canonica; Enrico Heffler
Journal:  Multidiscip Respir Med       Date:  2019-11-04

Review 4.  EUFOREA consensus on biologics for CRSwNP with or without asthma.

Authors:  Wytske J Fokkens; Valerie Lund; Claus Bachert; Joaquim Mullol; Leif Bjermer; Jean Bousquet; Giorgio W Canonica; Lauren Deneyer; Martin Desrosiers; Zuzana Diamant; Joseph Han; Enrico Heffler; Claire Hopkins; Roger Jankowski; Guy Joos; Andrew Knill; Jivianne Lee; Stella E Lee; Gert Mariën; Benoit Pugin; Brent Senior; Sven F Seys; Peter W Hellings
Journal:  Allergy       Date:  2019-07-15       Impact factor: 13.146

Review 5.  Acute exacerbations of chronic rhinosinusitis: The current state of knowledge.

Authors:  Zoe A Walters; Ahmad R Sedaghat; Katie M Phillips
Journal:  Laryngoscope Investig Otolaryngol       Date:  2022-07-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.